International Journal of Clinical Pharmacy

, Volume 36, Issue 2, pp 287–290 | Cite as

Influence of pharmaceutical care on the delayed emesis associated with chemotherapy

  • Fátima CaracuelEmail author
  • Úrsula Baños
  • María Dolores Herrera
  • Gabriel Ramírez
  • Nuria Muñoz
Short Research Report


Background Complete control of emesis during chemotherapy remains to be achieved. This could be improved by increasing adherence to medicines and recommendations. Objective The aim of this study was to analyse the effects of pharmaceutical care on the incidence of delayed chemotherapy-induced nausea and vomiting (CINV) in adult cancer outpatients. Method This is a longitudinal prospective intervention study. Patients included were those who received a new cancer intravenous treatment. We compared complete response (no vomiting and no rescue treatment) and the incidence of nausea in the control group (CG) and in the intervention group (IG), as well as patients’ adherence. Pharmaceutical intervention consisted of: reviewing the antiemetic protocol and giving some recommendations to the patients. Results 102 patients were studied. In the delayed phase complete response was achieved in 84.8 % of the patients in the IG, compared with 69.6 % in the control group [absolute risk reduction (ARR), 15.2 %; p = 0.144]. Regarding absence of vomiting, the difference was higher (71.0 CG vs 97.0 % IG, ARR, 26.0%; p = 0.002). Absence of delayed nausea were also better in the IG (61 vs. 52 %). Compliant patients increased from 59 to 76 %. Conclusion The intervention of a pharmacist reduced the incidence of delayed CINV and improved medication adherence.


Antiemetics Cancer chemotherapy CINV Incidence Pharmacist Vomiting 



Control group


Chemotherapy-induced nausea and vomiting


Complete response




Intervention group


Nausea and vomiting



The authors thank Beatriz Puche Valdayo and Chris Mott for their reading and advice to prepare this manuscript, Juan Polo for his help with statistical analysis. We also like to thank the nursing and medical staff for their collaboration.


No external funding has been obtained for the study.

Conflicts of interest

None to declare.


  1. 1.
    García JJ, Buil P, Ibarra M, Casas J, Paniagua I. Información al paciente para mejorar el control de la emesis retardada (Patient information to improve delayed emesis control). Farm Hosp 2000; 24.Google Scholar
  2. 2.
    Ishiara M, Iihara H, Okayasu S, Yasuda K, Matsuura K, Suzui M, et al. Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients. Support Care Cancer. 2010;18(12):1531–8.CrossRefGoogle Scholar
  3. 3.
    Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM. American Society of clinical oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol. 2006;24(18):2932–47.PubMedCrossRefGoogle Scholar
  4. 4.
    Hesketh PJ. Chemotherapy-induced nausea and vomiting. N Engl J Med. 2008;358(23):2482–94.PubMedCrossRefGoogle Scholar
  5. 5.
    Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS. 2006. (Accessed 20 Oct 2013).
  6. 6.
    Huertas MJ, Martínez MJ, Sánchez I, Zarzuela M, Baena JM. Análisis de la efectividad de un protocolo de antiemesis implantado en la Unidad de Oncología (Analysis of the effectiveness of a protocol implemented in Oncology Day Unit). Farm Hosp. 2010;34(3):125–38.CrossRefGoogle Scholar
  7. 7.
    Martin I, Montheil V, Ropert S, Alexandre J, Goldwasser F, Durand JP. Incidence of chemotherapy-induced nausea and vomiting in 2008. J Clin Oncol. 2009;27:e20660.CrossRefGoogle Scholar
  8. 8.
    Clifford S, Barber N, Elliott R, Hartley E, Horne R. Patient-centred advice is effective in improving adherence to medicines. Pharm World Sci. 2006;28(3):165–70.PubMedCrossRefGoogle Scholar
  9. 9.
    Mansoor LE, Dowse R. Medicines information and adherence in HIV/AIDS patients. J Clin Pharm Ther. 2006;31(1):7–15.PubMedCrossRefGoogle Scholar
  10. 10.
    Chan A, Low XH, Yap KY. Assessment of the relationship between adherence with antiemetic drug therapy and control of nausea and vomiting in breast cancer patients receiving anthracycline-based chemotherapy. J Manag Care Pharm. 2012;18(5):385–94.PubMedGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  • Fátima Caracuel
    • 1
    Email author
  • Úrsula Baños
    • 2
  • María Dolores Herrera
    • 3
  • Gabriel Ramírez
    • 2
  • Nuria Muñoz
    • 2
  1. 1.Virgen Macarena University HospitalSevilleSpain
  2. 2.Virgen Macarena University HospitalSevilleSpain
  3. 3.University of SevilleSevilleSpain

Personalised recommendations